Annual Current Liabilities
$64.06 M
+$45.46 M+244.32%
December 31, 2022
Summary
- As of February 9, 2025, TCRR annual total current liabilities is $64.06 million, with the most recent change of +$45.46 million (+244.32%) on December 31, 2022.
- During the last 3 years, TCRR annual current liabilities has risen by +$56.53 million (+750.40%).
Performance
TCRR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$47.47 M
-$16.59 M-25.89%
March 31, 2023
Summary
- As of February 9, 2025, TCRR quarterly total current liabilities is $47.47 million, with the most recent change of -$16.59 million (-25.89%) on March 31, 2023.
- Over the past year, TCRR quarterly current liabilities has increased by +$16.61 million (+53.80%).
Performance
TCRR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TCRR Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +244.3% | +53.8% |
| 3 y3 years | +750.4% | +674.6% |
| 5 y5 years | +5104.0% | - |
TCRR Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -71.0% | -25.9% | -60.8% |
| 5 y | 5-year | at high | -88.2% | -25.9% | -87.1% |
| alltime | all time | at high | -98.5% | -25.9% | -97.4% |
TCR2 Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $47.47 M(-25.9%) |
| Dec 2022 | $64.06 M(+244.3%) | $64.06 M(+74.6%) |
| Sep 2022 | - | $36.69 M(-4.9%) |
| Jun 2022 | - | $38.57 M(+25.0%) |
| Mar 2022 | - | $30.87 M(+65.9%) |
| Dec 2021 | $18.61 M(+110.5%) | $18.61 M(+12.6%) |
| Sep 2021 | - | $16.52 M(+10.5%) |
| Jun 2021 | - | $14.95 M(+42.1%) |
| Mar 2021 | - | $10.52 M(+19.0%) |
| Dec 2020 | $8.84 M | $8.84 M(+12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $7.85 M(+23.5%) |
| Jun 2020 | - | $6.36 M(+3.8%) |
| Mar 2020 | - | $6.13 M(-18.6%) |
| Dec 2019 | $7.53 M(+37.8%) | $7.53 M(-4.4%) |
| Sep 2019 | - | $7.88 M(+10.1%) |
| Jun 2019 | - | $7.16 M(+33.7%) |
| Mar 2019 | - | $5.36 M(-2.0%) |
| Dec 2018 | $5.46 M(+343.9%) | $5.46 M(+44.1%) |
| Sep 2018 | - | $3.79 M(+208.0%) |
| Dec 2017 | $1.23 M(+27.4%) | $1.23 M |
| Dec 2016 | $966.00 K | - |
FAQ
- What is TCR2 Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual current liabilities year-on-year change?
- What is TCR2 Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly current liabilities year-on-year change?
What is TCR2 Therapeutics annual total current liabilities?
The current annual current liabilities of TCRR is $64.06 M
What is the all time high annual current liabilities for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual total current liabilities is $64.06 M
What is TCR2 Therapeutics annual current liabilities year-on-year change?
Over the past year, TCRR annual total current liabilities has changed by +$45.46 M (+244.32%)
What is TCR2 Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TCRR is $47.47 M
What is the all time high quarterly current liabilities for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly total current liabilities is $64.06 M
What is TCR2 Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TCRR quarterly total current liabilities has changed by +$16.61 M (+53.80%)